Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Metals and Mining Industry News Why Korab Resources Limited’s Rum Jungle lease setback could reshape its strategic roadmap Korab Resources faces legal setback on Rum Jungle leases MLN542 and MLN543. Find out what this means for its mining roadmap and investor confidence. byPallavi MadhirajuJuly 5, 2025